Emily A. Xue

654 citations
4 papers · 381 indexed · h-index 2
Topics
Cancer Cells and Metastasis (3 papers)Nanoplatforms for cancer theranostics (1 paper)Dementia and Cognitive Impairment Research (1 paper)
Partner nations
United States

In The Last Decade

Emily A. Xue

4 papers receiving 377 citations

Peers

Emily A. Xue
Comparison fields: 5 of 57
  • Oncology 212
  • Molecular Biology 150
  • Cancer Research 115
  • Immunology 101
  • Biomedical Engineering 65
Replace Hengbo Zhou with:
Hengbo Zhou United States
Elizabeth A. Loughran United States
Ruping Yan China
Deanna Tiek United States
Dorcas A. Annan Japan
Ki-Chun Yoo South Korea
Shane W. O’Brien United States
Xueming Zhu United States
Mara De Martino United States
Emily A. Xue relative to Hengbo Zhou United States Hengbo Zhou's profile →
Citations per field
00.5×1.5×
Hengbo Zhou · 1×
Citations per year

Countries citing papers authored by Emily A. Xue

Since Specialization
Citations

This map shows the geographic impact of Emily A. Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Xue more than expected).

Fields of papers citing papers by Emily A. Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Xue. The network helps show where Emily A. Xue may publish in the future.

Co-authorship network of co-authors of Emily A. Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Xue. A scholar is included among the top collaborators of Emily A. Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Xue. Emily A. Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 17
2 362
3 1
4
Creating an Online CME Module: Early Detection and Diagnosis of Dementia and Alzheimer’s Disease
1

About Emily A. Xue

Emily A. Xue is a scholar working on Geriatrics and Gerontology, Modeling and Simulation and Oncology, having authored 4 papers that have together received 381 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Nanoplatforms for cancer theranostics (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Oncology (212 citations), Cancer Research (115 citations) and Immunology (101 citations). Emily A. Xue has collaborated with scholars based in United States. Frequent co-authors include Yarong Wang, Maja H. Oktay, George S. Karagiannis, Joan G. Jones, David Entenberg, John S. Condeelis, Ved P. Sharma, Thomas E. Rohan, Jessica Pastoriza and Jeanine Pignatelli. Their work appears in journals such as Cancer Research, Science Translational Medicine and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026